UK-based firm gets $14.3M boost | Vanadis Diagnostics acquired by PerkinElmer | Equity funding round pulls in $2.1M for GTX Surgery
January 29, 2016
ADVAMED SmartBrief
News for medical technology professionals

Top Story
UK-based firm gets $14.3M boost
Multiple funding rounds have pulled in $14.3 million for UK-based firm Vascular Flow Technologies. The company will use the money to support out-licensing and strategic joint development deals with partners, as well as research and development. (Boston) (1/28)
Share: LinkedInTwitterFacebookGoogle+Email
Business & Market Trends
Vanadis Diagnostics acquired by PerkinElmer
PerkinElmer has agreed to pay an undisclosed sum to purchase Sweden-based Vanadis Diagnostics. Vanadis is working on using digital analysis of cell-free DNA for a noninvasive prenatal testing solution. The acquisition is expected to build upon the maternal fetal health products of PerkinElmer. FDAnews (1/28)
Share: LinkedInTwitterFacebookGoogle+Email
Equity funding round pulls in $2.1M for GTX Surgery
A round of equity financing involving four unnamed investors has brought in $2.1 million for GTX Surgery. The mobile developer is creating medical simulations for smartphones and other mobile devices using video game technologies. (Boston) (1/28)
Share: LinkedInTwitterFacebookGoogle+Email
Molecular, sequencing units drive 2015 sales growth for Roche
Swiss pharmaceutical and diagnostics firm Roche Holding said its molecular diagnostics sales increased 7% from 2014, reaching $1.68 billion in 2015. The company attributed the growth to its sequencing and molecular units. GenomeWeb Daily News (free registration) (1/28)
Share: LinkedInTwitterFacebookGoogle+Email
Coroneo, Admedus reach distribution deal
Admedus has made a deal to exclusively distribute the heart valve surgical instruments and aortic annuloplasty ring of Canada-based Coroneo in the UK and Germany starting in April. FDAnews (1/28)
Share: LinkedInTwitterFacebookGoogle+Email
New CFO, vice president named by Stryker
Glenn Boehnlein has been tapped to serve as vice president and CFO of Stryker starting April 1. He succeeds William Jellison, who announced his retirement. Boehnlein is group chief financial officer at MedSurg & Neurotechnology. FDAnews (1/28)
Share: LinkedInTwitterFacebookGoogle+Email
Science & Health
Accelerator welcomes 13 digital health firms
The Innovation Institute of Texas Medical Center has tapped 13 startups to join the digital health program of its TMCx accelerator that will be held from January to June. Among the participants are Aprenda Systems, which has created a tool for gathering and managing health data, and CareSet Systems, which is focused on establishing physician networks. A program for medical device firms will also be held by the accelerator from July to December. (1/27)
Share: LinkedInTwitterFacebookGoogle+Email
Emerging Technologies
Drugmakers look to the Internet for data collection
Novartis is working with Qualcomm to develop an inhaler that can connect to the Internet to communicate information about usage of the emphysema drug Onbrez. Wide adoption of similar technology has the potential to yield massive amounts of data about drug efficacy and medical conditions. Roche, Novo Nordisk and GlaxoSmithKline are also looking at connected technology. The Economic Times (India) (1/27)
Share: LinkedInTwitterFacebookGoogle+Email
Government & Regulatory
2 MRI-safe pacemakers from LivaNova win approval in Japan
Japanese regulators have given London-based LivaNova approval to commercialize two MRI-safe pacemakers in that country. The approval covers the company's Kora 250 DR and Kora 250 SR devices. (Boston) (1/28)
Share: LinkedInTwitterFacebookGoogle+Email
Lung cancer test from Veracyte gets approval in N.Y.
Veracyte's Percepta Bronchial Genomic Classifier has been approved by the New York State Department of Health. The test, which identifies patients who have lung lesions or nodules but are at low risk for cancer, can be used in patients with unclear bronchoscopy findings. GenomeWeb Daily News (free registration) (1/28)
Share: LinkedInTwitterFacebookGoogle+Email
AdvaMed Events and Education
Defining Value Webinar: Implications of New Value Frameworks for Devices
March 4 | Webinar
During this one-hour webinar, you will hear an update on comparative effectiveness research in the US. Value and implications for devices will be discussed. Agenda topics include changing market access, the role of new insurance benefit designs, the role of patient-centered care and more. You'll benefit from this webinar if you are involved with market access, HEOR or development and commercialization. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
AdvaMed-BRG Compliance Executive Speaker Series
April 13, Irvine, Calif. | May 18,  Sunnyvale, Calif. Sept. 14, Chicago, Ill. | Oct. 26, Boston, Mass.
AdvaMed and BRG are excited to announce the inaugural Compliance Executive Speaker Series. We'll be coming to an area near you with a series of one-day, highly interactive small-group sessions that will deliver in-depth content, expert industry speakers, case studies and best practices on emerging compliance issues facing the medical device industry. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
powered by
Medical Devices Biostatistics Manager
Sr. Regulatory Affairs Openings
The main ingredient of stardom is the rest of the team."
-- John Wooden,
basketball player and coach
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Advertising:  Meryl Harold
  P: 202.407.7828
Jobs Contact:
Editor:  Lisa Gough

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information